Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shuto

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|March 22, 2019
Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like BehaviorsWataru Ichinose, Stanislav M Cherepanov, Anna A Shabalova, et al.
Plos One|June 13, 2015
Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced ResponsesAyaka Tobo, Masayuki Tobo, Takashi Nakakura, et al.
Messenger (Los Angeles, Calif. : Print)|May 21, 2016
Design, Synthesis, and Chemical and Biological Properties of Cyclic ADP-4-Thioribose as a Stable Equivalent of Cyclic ADP-RiboseTakayoshi Tsuzuki, Satoshi Takano, Natsumi Sakaguchi, et al.
Molecular Pharmaceutics|August 20, 2011
Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistanceKatarina Johansson, Mika Ito, Carolien M S Schophuizen, et al.
Angewandte Chemie (International Ed. in English)|May 15, 2013
Design and synthesis of cyclic ADP-4-thioribose as a stable equivalent of cyclic ADP-ribose, a calcium ion-mobilizing second messengerTakayoshi Tsuzuki, Natsumi Sakaguchi, Takashi Kudoh, et al.
Journal of Medicinal Chemistry|February 21, 2012
Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitorsSeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 31, 2019
Resolvin E3 attenuates allergic airway inflammation <i>via</i> the interleukin-23-interleukin-17A pathwayMakiko Sato, Haruka Aoki-Saito, Hayato Fukuda, et al.
Journal of Medicinal Chemistry|May 22, 2012
Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategySeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|June 22, 2012
1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitorsHitoshi Miyakoshi, Seiji Miyahara, Tatsushi Yokogawa, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2021
Structure, solubility, and permeability relationships in a diverse middle molecule libraryHiroyuki Miyachi, Kayoko Kanamitsu, Mayumi Ishii, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|March 22, 2019
Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like BehaviorsWataru Ichinose, Stanislav M Cherepanov, Anna A Shabalova, et al.
Plos One|June 13, 2015
Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced ResponsesAyaka Tobo, Masayuki Tobo, Takashi Nakakura, et al.
Messenger (Los Angeles, Calif. : Print)|May 21, 2016
Design, Synthesis, and Chemical and Biological Properties of Cyclic ADP-4-Thioribose as a Stable Equivalent of Cyclic ADP-RiboseTakayoshi Tsuzuki, Satoshi Takano, Natsumi Sakaguchi, et al.
Molecular Pharmaceutics|August 20, 2011
Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistanceKatarina Johansson, Mika Ito, Carolien M S Schophuizen, et al.
Angewandte Chemie (International Ed. in English)|May 15, 2013
Design and synthesis of cyclic ADP-4-thioribose as a stable equivalent of cyclic ADP-ribose, a calcium ion-mobilizing second messengerTakayoshi Tsuzuki, Natsumi Sakaguchi, Takashi Kudoh, et al.
Journal of Medicinal Chemistry|February 21, 2012
Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitorsSeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 31, 2019
Resolvin E3 attenuates allergic airway inflammation <i>via</i> the interleukin-23-interleukin-17A pathwayMakiko Sato, Haruka Aoki-Saito, Hayato Fukuda, et al.
Journal of Medicinal Chemistry|May 22, 2012
Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategySeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|June 22, 2012
1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitorsHitoshi Miyakoshi, Seiji Miyahara, Tatsushi Yokogawa, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2021
Structure, solubility, and permeability relationships in a diverse middle molecule libraryHiroyuki Miyachi, Kayoko Kanamitsu, Mayumi Ishii, et al.
Pageof 19